ash23: iberdomide maintenance in emn26 study post stem-cell transplant | neils van de donk, md, phd
Published 6 months ago • 277 plays • Length 8:37
Download video MP4
Download video MP3
Similar videos
-
3:07
ash 2023 | emn26 clinical trial
-
5:23
karmma-2 cohort 2b update: ide-cel for transplant-ineligible patients with high-risk myeloma
-
10:43
ash23: elranatamab effective in relapsed myeloma post-bcma car-t | daniel sherbenou, md, phd
-
6:40
ash23: frontline treatment drd vs. vrd for transplant-ineligible myeloma patients | doris hansen, md
-
2:50
is the imf’s ascent trial curing smoldering myeloma patients?
-
20:10
pushing toward tomorrow - amrita krishnan, md, facp | rt irvine, ca nov 5, 2022
-
56:47
bone marrow transplant in mds and aml
-
2:12
ash 2023 | minimal residual disease (mrd) measurement in myeloma
-
5:06
imroz- isarvd vs rvd in newly diagnosed transplant ineligible mm | thierry facon, md | eha 2024
-
1:49
ai-driven immunofluorescence pattern recognition in aibds, n. capurro et al.
-
9:52
ash23: post ash summary | joseph mikhael, md
-
5:05
myeloma university | overview of autologous stem cell transplant for treatment of multiple myeloma
-
2:43
safety and efficacy of isa/bor/len/dex for ndmm ineligible/with no immediate intent for asct
-
1:48
the role of autologous transplantation in young and fit patients with multiple myeloma in 2022
-
4:34
what is ide-cel and how can it benefit myeloma patients?
-
1:35
immunotherapy and targeted treatment for mcrc | dustin deming, md | esmo22 pennsylvania
-
3:11
bispecific antibodies | joshua richter, md | ash 2022
-
10:21
ash23: impact of dexamethasone (dex) dose strength on newly diagnosed myeloma | rahul banerjee, md
-
2:49:49
multiple myeloma: an update from ash - dec 2022
-
3:46
idh2 mutation allows myelod differentiation #aml | jane liesveld | ash 2023
-
2:34
new salvage treatment for aml/mds after allogeneic transplant: the viola trial
Clip.africa.com - Privacy-policy